Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
07 February 2018 Photo ICC
Raynard named captain of the Team of the Tournament at U-19 World Cup
Raynard van Tonder, right, is congratulated by fellow player Hermann Rolfes after scoring his second century against Bangladesh at the U-19 Cricket World Cup in New Zealand.

Raynard van Tonder was rewarded for an outstanding U-19 World Cup in New Zealand when he was named as the captain of the Team of the Tournament, announced by the International Cricket Council on Sunday.

The Kovsie cricketer, who captained the South African team to fifth place, ended with the third-most runs in the tournament; 348 in six matches at an impressive average of 69.6. He scored two centuries (one of three players to achieve this) and one 50. It included a knock of 143 against Kenya, which was the fifth-highest in the tournament. With that, the 19-year-old also recorded the third-highest score ever by a South African in an U-19 One Day International.

Van Tonder is studying a BSocSci at the University of the Free State (UFS).

Congratulations from CSA

“It is heartening to know
that we continue to produce
quality players and leaders.”
—Thabang Moroe
Acting Chief Executive
of Cricket South Africa

“Raynard deserves a special commendation for being chosen as the best leader at the tournament. This follows on our 2014 captain, Aiden Markram (currently leading the Proteas in the one-day series against India), who was chosen as Player of the Tournament back then.

“It is heartening to know that we continue to produce quality players and leaders through our talent pipeline system,” commented acting chief executive of Cricket South Africa (CSA), Thabang Moroe.

The Team of the ICC U-19 Cricket World Cup was selected by a panel that comprised former Windies fast bowler Ian Bishop, former India women’s captain Anjum Chopra, former New Zealand captain Jeff Crowe, journalist Shashank Kishore and former Australia all-rounder Tom Moody.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept